Workflow
趋势研判!2025年中国牛血清行业产业链、产业现状、重点企业及未来前景分析:生物医药等领域加速发展,牛血清应用需求持续增长[图]
Chan Ye Xin Xi Wang·2025-06-20 01:24

Industry Overview - Bovine serum is a key biological reagent derived from fresh bovine blood, containing various plasma proteins, peptides, and growth factors, essential for cell growth and physiological balance [1][2] - The demand for bovine serum has been increasing globally, particularly in China, where the market size is projected to grow from CNY 1.494 billion in 2017 to CNY 4.222 billion by 2024, with a compound annual growth rate (CAGR) of 16% [1][8] Upstream Industry - The upstream of the bovine serum industry includes cattle farming, blood collection institutions, and slaughterhouses, with China's cattle inventory reaching 100.465 million heads in 2024, showing a significant increase from 2013 [6] - The cattle slaughter volume and beef production also saw substantial growth, indicating an improving supply capacity for the bovine serum industry [6] Current Industry Status - Bovine serum plays an indispensable role in life sciences, drug development, and vaccine production, with its market size in China expected to reach CNY 4.222 billion by 2024 [8][12] - The market is primarily driven by the increasing demand in the biopharmaceutical sector, which is projected to grow from CNY 16.3 trillion in 2019 to CNY 21.4 trillion in 2024 [12] Downstream Applications - Bovine serum is widely used in biopharmaceuticals, cell culture, vaccine production, and biological research, with a notable increase in demand due to the rapid development of these sectors [12][14] - The vaccine market in China is also expanding, with the market size expected to grow from CNY 19.16 billion in 2015 to CNY 124.5 billion in 2024, further driving the demand for bovine serum [16] Competitive Landscape - The bovine serum market in China is characterized by a diverse competitive landscape, with domestic brands like Tianhang Bio and Minhai Bio leading in the new-born bovine serum segment, while high-end fetal bovine serum is dominated by imported brands [18][20] - Domestic companies are gradually achieving market share through quality control and cost advantages, particularly in the context of increasing demand from the biopharmaceutical and cell therapy industries [18] Market Trends - The market demand for bovine serum is expected to continue growing, driven by the expansion of the vaccine market and increasing needs in biological research and cell therapy [26] - There is a trend towards improving product quality and standardization in the bovine serum industry, with companies enhancing raw material management and adopting advanced production technologies [27] - Technological innovations and the development of serum-free culture media are emerging as potential alternatives, although bovine serum remains irreplaceable in certain applications [28]